THE Therapeutic Goods
Administration is warning
Australians of the presence of the
prescription-only Yohimbine in
OxyELITE Pro capsules.
Sold over the internet and
marketed as having super
thermogenic (weightloss)
properties, OxyELITE Pro is not
approved by the TGA, and supply
of the tablets is illegal.
Yohimbine is not approved for
supply in any registered medicine
within Australia, and can pose
serious health risks for people with
underlying risk factors.
As such, the TGA is advising
Aussies who have purchased
OxyELITE to cease use and discard
any remaining product.The above article was sent to subscribers in Pharmacy Daily's issue from 12 Jul 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Jul 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.